img

Global Nerve Block Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nerve Block Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Nerve block injection is a local anesthetic used during surgery to control pain and reduce or eliminate the use of opioids for acute postoperative pain.
Nerve Block Injection report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nerve Block Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nerve Block Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nerve Block Injection key manufacturers include Pfizer, Pacira, Fresenius Kabi, Aspen Pharmacare, AstraZeneca, Eugia US, Aurobindo, Akorn and Somerset Pharma, etc. Pfizer, Pacira, Fresenius Kabi are top 3 players and held % sales share in total in 2022.
Nerve Block Injection can be divided into Esters Local Anesthetics and Amide Local Anesthetics, etc. Esters Local Anesthetics is the mainstream product in the market, accounting for % sales share globally in 2022.
Nerve Block Injection is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Nerve Block Injection industry development. In 2022, global % sales of Nerve Block Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nerve Block Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Pacira
Fresenius Kabi
Aspen Pharmacare
AstraZeneca
Eugia US
Aurobindo
Akorn
Somerset Pharma
Amphastar Pharmaceuticals
Hikma
Segment by Type
Esters Local Anesthetics
Amide Local Anesthetics

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nerve Block Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Nerve Block Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Nerve Block Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Nerve Block Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Nerve Block Injection introduction, etc. Nerve Block Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Nerve Block Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Nerve Block Injection Market Overview
1.1 Nerve Block Injection Product Overview
1.2 Nerve Block Injection Market Segment by Type
1.2.1 Esters Local Anesthetics
1.2.2 Amide Local Anesthetics
1.3 Global Nerve Block Injection Market Size by Type
1.3.1 Global Nerve Block Injection Market Size Overview by Type (2018-2034)
1.3.2 Global Nerve Block Injection Historic Market Size Review by Type (2018-2024)
1.3.3 Global Nerve Block Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Nerve Block Injection Sales Breakdown by Type (2018-2024)
1.4.2 Europe Nerve Block Injection Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Nerve Block Injection Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Nerve Block Injection Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Nerve Block Injection Sales Breakdown by Type (2018-2024)
2 Global Nerve Block Injection Market Competition by Company
2.1 Global Top Players by Nerve Block Injection Sales (2018-2024)
2.2 Global Top Players by Nerve Block Injection Revenue (2018-2024)
2.3 Global Top Players by Nerve Block Injection Price (2018-2024)
2.4 Global Top Manufacturers Nerve Block Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Nerve Block Injection Market Competitive Situation and Trends
2.5.1 Nerve Block Injection Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Nerve Block Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nerve Block Injection as of 2022)
2.7 Date of Key Manufacturers Enter into Nerve Block Injection Market
2.8 Key Manufacturers Nerve Block Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Nerve Block Injection Status and Outlook by Region
3.1 Global Nerve Block Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Nerve Block Injection Historic Market Size by Region
3.2.1 Global Nerve Block Injection Sales in Volume by Region (2018-2024)
3.2.2 Global Nerve Block Injection Sales in Value by Region (2018-2024)
3.2.3 Global Nerve Block Injection Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Nerve Block Injection Forecasted Market Size by Region
3.3.1 Global Nerve Block Injection Sales in Volume by Region (2024-2034)
3.3.2 Global Nerve Block Injection Sales in Value by Region (2024-2034)
3.3.3 Global Nerve Block Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Nerve Block Injection by Application
4.1 Nerve Block Injection Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Nerve Block Injection Market Size by Application
4.2.1 Global Nerve Block Injection Market Size Overview by Application (2018-2034)
4.2.2 Global Nerve Block Injection Historic Market Size Review by Application (2018-2024)
4.2.3 Global Nerve Block Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Nerve Block Injection Sales Breakdown by Application (2018-2024)
4.3.2 Europe Nerve Block Injection Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Nerve Block Injection Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Nerve Block Injection Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Nerve Block Injection Sales Breakdown by Application (2018-2024)
5 North America Nerve Block Injection by Country
5.1 North America Nerve Block Injection Historic Market Size by Country
5.1.1 North America Nerve Block Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Nerve Block Injection Sales in Volume by Country (2018-2024)
5.1.3 North America Nerve Block Injection Sales in Value by Country (2018-2024)
5.2 North America Nerve Block Injection Forecasted Market Size by Country
5.2.1 North America Nerve Block Injection Sales in Volume by Country (2024-2034)
5.2.2 North America Nerve Block Injection Sales in Value by Country (2024-2034)
6 Europe Nerve Block Injection by Country
6.1 Europe Nerve Block Injection Historic Market Size by Country
6.1.1 Europe Nerve Block Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Nerve Block Injection Sales in Volume by Country (2018-2024)
6.1.3 Europe Nerve Block Injection Sales in Value by Country (2018-2024)
6.2 Europe Nerve Block Injection Forecasted Market Size by Country
6.2.1 Europe Nerve Block Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe Nerve Block Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific Nerve Block Injection by Region
7.1 Asia-Pacific Nerve Block Injection Historic Market Size by Region
7.1.1 Asia-Pacific Nerve Block Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Nerve Block Injection Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Nerve Block Injection Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Nerve Block Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Nerve Block Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Nerve Block Injection Sales in Value by Region (2024-2034)
8 Latin America Nerve Block Injection by Country
8.1 Latin America Nerve Block Injection Historic Market Size by Country
8.1.1 Latin America Nerve Block Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Nerve Block Injection Sales in Volume by Country (2018-2024)
8.1.3 Latin America Nerve Block Injection Sales in Value by Country (2018-2024)
8.2 Latin America Nerve Block Injection Forecasted Market Size by Country
8.2.1 Latin America Nerve Block Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America Nerve Block Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa Nerve Block Injection by Country
9.1 Middle East and Africa Nerve Block Injection Historic Market Size by Country
9.1.1 Middle East and Africa Nerve Block Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Nerve Block Injection Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Nerve Block Injection Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Nerve Block Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Nerve Block Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Nerve Block Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Nerve Block Injection Products Offered
10.1.5 Pfizer Recent Development
10.2 Pacira
10.2.1 Pacira Company Information
10.2.2 Pacira Introduction and Business Overview
10.2.3 Pacira Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pacira Nerve Block Injection Products Offered
10.2.5 Pacira Recent Development
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Company Information
10.3.2 Fresenius Kabi Introduction and Business Overview
10.3.3 Fresenius Kabi Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Fresenius Kabi Nerve Block Injection Products Offered
10.3.5 Fresenius Kabi Recent Development
10.4 Aspen Pharmacare
10.4.1 Aspen Pharmacare Company Information
10.4.2 Aspen Pharmacare Introduction and Business Overview
10.4.3 Aspen Pharmacare Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Aspen Pharmacare Nerve Block Injection Products Offered
10.4.5 Aspen Pharmacare Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca Nerve Block Injection Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Eugia US
10.6.1 Eugia US Company Information
10.6.2 Eugia US Introduction and Business Overview
10.6.3 Eugia US Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Eugia US Nerve Block Injection Products Offered
10.6.5 Eugia US Recent Development
10.7 Aurobindo
10.7.1 Aurobindo Company Information
10.7.2 Aurobindo Introduction and Business Overview
10.7.3 Aurobindo Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Aurobindo Nerve Block Injection Products Offered
10.7.5 Aurobindo Recent Development
10.8 Akorn
10.8.1 Akorn Company Information
10.8.2 Akorn Introduction and Business Overview
10.8.3 Akorn Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Akorn Nerve Block Injection Products Offered
10.8.5 Akorn Recent Development
10.9 Somerset Pharma
10.9.1 Somerset Pharma Company Information
10.9.2 Somerset Pharma Introduction and Business Overview
10.9.3 Somerset Pharma Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Somerset Pharma Nerve Block Injection Products Offered
10.9.5 Somerset Pharma Recent Development
10.10 Amphastar Pharmaceuticals
10.10.1 Amphastar Pharmaceuticals Company Information
10.10.2 Amphastar Pharmaceuticals Introduction and Business Overview
10.10.3 Amphastar Pharmaceuticals Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Amphastar Pharmaceuticals Nerve Block Injection Products Offered
10.10.5 Amphastar Pharmaceuticals Recent Development
10.11 Hikma
10.11.1 Hikma Company Information
10.11.2 Hikma Introduction and Business Overview
10.11.3 Hikma Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Hikma Nerve Block Injection Products Offered
10.11.5 Hikma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Nerve Block Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Nerve Block Injection Industrial Chain Analysis
11.4 Nerve Block Injection Market Dynamics
11.4.1 Nerve Block Injection Industry Trends
11.4.2 Nerve Block Injection Market Drivers
11.4.3 Nerve Block Injection Market Challenges
11.4.4 Nerve Block Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Nerve Block Injection Distributors
12.3 Nerve Block Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Esters Local Anesthetics
Table 2. Major Company of Amide Local Anesthetics
Table 3. Global Nerve Block Injection Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Nerve Block Injection Sales by Type (2018-2024) & (K Units)
Table 5. Global Nerve Block Injection Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Nerve Block Injection Sales by Type (2018-2024) & (US& Million)
Table 7. Global Nerve Block Injection Market Share in Value by Type (2018-2024)
Table 8. Global Nerve Block Injection Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Nerve Block Injection Sales by Type (2024-2034) & (K Units)
Table 10. Global Nerve Block Injection Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Nerve Block Injection Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Nerve Block Injection Sales Market Share in Value by Type (2024-2034)
Table 13. Global Nerve Block Injection Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Nerve Block Injection Sales by Type (2018-2024) & (K Units)
Table 15. North America Nerve Block Injection Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Nerve Block Injection Sales (K Units) by Type (2018-2024)
Table 17. Europe Nerve Block Injection Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Nerve Block Injection Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Nerve Block Injection Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Nerve Block Injection Sales (K Units) by Type (2018-2024)
Table 21. Latin America Nerve Block Injection Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Nerve Block Injection Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Nerve Block Injection Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Nerve Block Injection Sales by Company (2018-2024) & (K Units)
Table 25. Global Nerve Block Injection Sales Share by Company (2018-2024)
Table 26. Global Nerve Block Injection Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Nerve Block Injection Revenue Share by Company (2018-2024)
Table 28. Global Market Nerve Block Injection Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Nerve Block Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Nerve Block Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nerve Block Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into Nerve Block Injection Market
Table 33. Key Manufacturers Nerve Block Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Nerve Block Injection Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Nerve Block Injection Sales by Region (2018-2024) & (K Units)
Table 37. Global Nerve Block Injection Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Nerve Block Injection Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Nerve Block Injection Sales Market Share in Value by Region (2018-2024)
Table 40. Global Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Nerve Block Injection Sales by Region (2024-2034) & (K Units)
Table 42. Global Nerve Block Injection Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Nerve Block Injection Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Nerve Block Injection Sales Market Share in Value by Region (2024-2034)
Table 45. Global Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Nerve Block Injection Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Nerve Block Injection Sales by Application (2018-2024) & (K Units)
Table 48. Global Nerve Block Injection Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Nerve Block Injection Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Nerve Block Injection Sales Market Share in Value by Application (2018-2024)
Table 51. Global Nerve Block Injection Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Nerve Block Injection Sales by Application (2024-2034) & (K Units)
Table 53. Global Nerve Block Injection Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Nerve Block Injection Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Nerve Block Injection Sales Market Share in Value by Application (2024-2034)
Table 56. Global Nerve Block Injection Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Nerve Block Injection Sales by Application (2018-2024) (K Units)
Table 58. North America Nerve Block Injection Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Nerve Block Injection Sales by Application (2018-2024) (K Units)
Table 60. Europe Nerve Block Injection Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Nerve Block Injection Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Nerve Block Injection Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Nerve Block Injection Sales by Application (2018-2024) (K Units)
Table 64. Latin America Nerve Block Injection Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Nerve Block Injection Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Nerve Block Injection Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 68. North America Nerve Block Injection Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Nerve Block Injection Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Nerve Block Injection Sales Market Share in Value by Country (2018-2024)
Table 71. North America Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 72. North America Nerve Block Injection Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Nerve Block Injection Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Nerve Block Injection Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 76. Europe Nerve Block Injection Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Nerve Block Injection Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Nerve Block Injection Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 80. Europe Nerve Block Injection Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Nerve Block Injection Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Nerve Block Injection Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Nerve Block Injection Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Nerve Block Injection Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Nerve Block Injection Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Nerve Block Injection Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Nerve Block Injection Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Nerve Block Injection Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Nerve Block Injection Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Nerve Block Injection Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Nerve Block Injection Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Nerve Block Injection Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Nerve Block Injection Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Nerve Block Injection Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Nerve Block Injection Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Nerve Block Injection Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Nerve Block Injection Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Nerve Block Injection Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Nerve Block Injection Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Nerve Block Injection Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Nerve Block Injection Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Nerve Block Injection Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Nerve Block Injection Product
Table 111. Pfizer Recent Development
Table 112. Pacira Company Information
Table 113. Pacira Introduction and Business Overview
Table 114. Pacira Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Pacira Nerve Block Injection Product
Table 116. Pacira Recent Development
Table 117. Fresenius Kabi Company Information
Table 118. Fresenius Kabi Introduction and Business Overview
Table 119. Fresenius Kabi Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Fresenius Kabi Nerve Block Injection Product
Table 121. Fresenius Kabi Recent Development
Table 122. Aspen Pharmacare Company Information
Table 123. Aspen Pharmacare Introduction and Business Overview
Table 124. Aspen Pharmacare Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Aspen Pharmacare Nerve Block Injection Product
Table 126. Aspen Pharmacare Recent Development
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Introduction and Business Overview
Table 129. AstraZeneca Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. AstraZeneca Nerve Block Injection Product
Table 131. AstraZeneca Recent Development
Table 132. Eugia US Company Information
Table 133. Eugia US Introduction and Business Overview
Table 134. Eugia US Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Eugia US Nerve Block Injection Product
Table 136. Eugia US Recent Development
Table 137. Aurobindo Company Information
Table 138. Aurobindo Introduction and Business Overview
Table 139. Aurobindo Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Aurobindo Nerve Block Injection Product
Table 141. Aurobindo Recent Development
Table 142. Akorn Company Information
Table 143. Akorn Introduction and Business Overview
Table 144. Akorn Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Akorn Nerve Block Injection Product
Table 146. Akorn Recent Development
Table 147. Somerset Pharma Company Information
Table 148. Somerset Pharma Introduction and Business Overview
Table 149. Somerset Pharma Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Somerset Pharma Nerve Block Injection Product
Table 151. Somerset Pharma Recent Development
Table 152. Amphastar Pharmaceuticals Company Information
Table 153. Amphastar Pharmaceuticals Introduction and Business Overview
Table 154. Amphastar Pharmaceuticals Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Amphastar Pharmaceuticals Nerve Block Injection Product
Table 156. Amphastar Pharmaceuticals Recent Development
Table 157. Hikma Company Information
Table 158. Hikma Introduction and Business Overview
Table 159. Hikma Nerve Block Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Hikma Nerve Block Injection Product
Table 161. Hikma Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Nerve Block Injection Market Trends
Table 165. Nerve Block Injection Market Drivers
Table 166. Nerve Block Injection Market Challenges
Table 167. Nerve Block Injection Market Restraints
Table 168. Nerve Block Injection Distributors List
Table 169. Nerve Block Injection Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Nerve Block Injection Product Picture
Figure 2. Global Nerve Block Injection Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Nerve Block Injection Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Nerve Block Injection Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Esters Local Anesthetics
Figure 6. Global Esters Local Anesthetics Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Amide Local Anesthetics
Figure 8. Global Amide Local Anesthetics Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Nerve Block Injection Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Nerve Block Injection Sales Market Share by Type in 2022 & 2034
Figure 11. North America Nerve Block Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America Nerve Block Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe Nerve Block Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe Nerve Block Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Nerve Block Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Nerve Block Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America Nerve Block Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Nerve Block Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Nerve Block Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Nerve Block Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Nerve Block Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Nerve Block Injection Revenue in 2022
Figure 23. Nerve Block Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Nerve Block Injection Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Nerve Block Injection Sales Market Share by Application in 2022 & 2034
Figure 32. North America Nerve Block Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America Nerve Block Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe Nerve Block Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe Nerve Block Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Nerve Block Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Nerve Block Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America Nerve Block Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Nerve Block Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Nerve Block Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Nerve Block Injection Manufacturing Cost Structure
Figure 43. Nerve Block Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed